M. Belizan,F. Augustovski,A. Bardach,T. Pinto,A. Villarejo,E. Lazo,M. V. Cordo and D. A. M. van Oorschot. Patient Experience of Herpes Zoster Disease in Argentina: Validation of a Health-Related Quality of Life Conceptual Model. Value Health Reg Issues. 2024;44:10.1016/j.vhri.2024.101044.
N. Matamoros,M. Puchulu,J. Colman Lerner,E. Maury-Sintjago,J. López,V. Sosio,J. Belizán,A. Porta and G. Cormick. Feasibility of increasing calcium content of drinking tap water following quality regulations to improve calcium intake at population level [version 2; peer review: 2 approved]. Gates Open Research. 2024;8(5):10.12688/gatesopenres.15184.2.
M. Saban,D. Zavala,A. Lopez Osornio,D. Kaminker,M. Díaz,A. Rubinstein,S. Esteban and D. A. Rizzato Lede. Understanding WHO SMART Guidelines: Narrative Review of an Innovative Global Digital Health Approach. Stud Health Technol Inform. 2024;316:10.3233/shti240825.
C. Moreno,A. Bardach,M. C. Palermo,M. M. Sandoval,E. Baumeister,S. Ruvinsky,R. Ulloa-Gutiérrez,K. Stegelmann,S. Ardiles Ruesjas,J. LaRotta,R. Sini de Almeida and A. Ciapponi. Economic burden of respiratory syncytial virus disease in Latin America: A systematic review. Hum Vaccin Immunother. 2024;20(1):10.1080/21645515.2024.2381298.
F. Argento,A. Bardach,E. Navarro and A. González-Marrón. Estimation of the population at high risk of developing lung cancer in Chile using simplified eligibility criteria. Public Health. 2024;234:https://doi.org/10.1016/j.puhe.2024.06.012.
J. P. Alonso,N. Ini,A. Villarejo,M. Belizán and J. Roberti. Amyotrophic lateral sclerosis in Argentina: unveiling the burden of treatment through patient and caregiver perspectives. Disability and Rehabilitation. 2024:10.1080/09638288.2024.2385732.
A. Ciapponi,M. Berrueta,F. J. Argento,J. Ballivian,A. Bardach,M. E. Brizuela,N. Castellana,D. Comandé,S. Gottlieb,B. Kampmann,A. Mazzoni,E. P. K. Parker,J. M. Sambade,K. Stegelmann,X. Xiong,A. Stergachis and P. Buekens. Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis. Drug Safety. 2024:10.1007/s40264-024-01458-w.
N. Espinola,C. Silvestrini,C. Colaci,D. Sugg,C. Rojas-Roque,J. Coelli and F. Augustovski. Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - Open. 2024:10.1007/s41669-024-00508-4.
K. L. Cordova-Pozoand J. M. Belizán. Scale-up interventions-Moving from pilot projects to larger implementation settings. Reprod Health. 2024;21(1):10.1186/s12978-024-01843-9.
Scale-up interventions-Moving from pilot projects to larger implementation settings Ver más »
Y. B. Okwaraji,L. Suárez-Idueta,E. O. Ohuma,E. Bradley,J. Yargawa,V. Pingray,G. Cormick,A. Gordon,V. Flenady,E. Horváth-Puhó,H. T. Sørensen,L. Abuladze,M. Heidarzadeh,N. Khalili,K. A. Yunis,A. Al Bizri,A. Barranco,A. E. van Dijk,L. Broeders,F. Alyafei,T. O. Olukade,N. Razaz,J. Söderling,L. K. Smith,R. J. Matthews,R. Wood,K. Monteath,I. Pereyra,G. Pravia,S. Lisonkova,Q. Wen,J. E. Lawn and H. Blencowe. Stillbirth risk by fetal size among 126.5 million births in 15 countries from 2000 to 2020: A fetuses-at-risk approach. Bjog. 2024:10.1111/1471-0528.17890.
